📊 Evidence-Based Reference

Gunther Tulip Vena Cava Filter Set for Femoral Vein Approach Gunther Tulip Vena Cava Filter Set for Femoral and Jugular Vein Approach

William Cook Europe ApS

Contact a rep Compare similar devices

Summary: The Gunther Tulip Vena Cava Filter is a device used to prevent pulmonary embolism by capturing blood clots. Key evidence highlights its retrieval challenges and complications.

FDA Clearance Information

Pathway ? 510(k)
Number ? K172584 ↗
Decision Date ? November 20, 2017
Product Code ? DTK Filter, Intravascular, Cardiovascular
Device Class ? Class 2
Evidence ? 10 studies

The Gunther Tulip Vena Cava Filter was cleared by the FDA via the 510(k) pathway on November 20, 2017. It is manufactured by William Cook Europe Aps and is classified as a Class 2 medical device.

What It Is

The Gunther Tulip Vena Cava Filter is a medical device designed to capture blood clots in the inferior vena cava to prevent pulmonary embolism. It is intended for temporary or permanent placement in patients at risk of thromboembolic events.

FDA-Cleared Indications

  • Use in patients at risk for pulmonary embolism when protection from venous thromboembolism is clinically indicated.
  • Use when anticoagulation is contraindicated, not tolerated, or ineffective.
  • Placement through either a femoral vein or jugular vein approach.

Clinical Applications

  • Inferior vena cava filter placement for prevention of pulmonary embolism in selected patients with venous thromboembolism.
  • Temporary filter placement when anticoagulation cannot be used or must be interrupted.
  • Filter placement in patients with recurrent thromboembolic events despite anticoagulation.
  • Retrieval of the filter when protection is no longer clinically needed and removal is feasible.

Reported off-label uses

  • Use for selected patients without documented venous thromboembolism but considered at unusually high risk of pulmonary embolism.
  • Placement in an atypical venous location when standard inferior vena cava placement is not feasible.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The available literature includes 11 studies, comprising case reports and retrospective analyses, published between 2011 and 2020. These studies explore the device's efficacy, retrieval challenges, and safety profile.

Reported Outcomes

Published studies report that the Gunther Tulip Vena Cava Filter is effective in preventing pulmonary embolism. However, retrieval can be challenging, especially if the filter becomes embedded in the vena cava wall or migrates. Successful retrievals have been documented using alternative techniques.

Safety Profile

Reported complications include filter migration, embedding in the vena cava wall, and perforation of the vena cava. These events can complicate retrieval and may require endovascular repair.

Evidence Limitations

The evidence is limited by the small number of studies and the retrospective nature of most reports. Further research is needed to assess long-term outcomes and optimize retrieval techniques.

Practical Considerations

  • The system is designed for delivery through either the femoral or jugular venous approach; the appropriate access route depends on anatomy, thrombus location, and the planned filter position.
  • Available filter and delivery-system sizes should be matched to the patient's inferior vena cava diameter and the specific product instructions for use.
  • Placement and retrieval are performed under imaging guidance, commonly fluoroscopy, with venography or other imaging used to assess anatomy and thrombus.
  • Potential complications include access-site bleeding, filter migration, tilt, fracture, perforation of the vena cava, thrombosis, and difficulty or inability to retrieve the filter.
  • MRI conditions and scan limits should be confirmed in the current manufacturer labeling before MRI. The device should not be assumed to be MR safe without reviewing its MR status.

Procedures that use this device

Linked Studies (10)

PubMed • 2022

Case report: Endoluminal removal of a retrievable conical inferior vena cava filter with a ruptured retraction hook attached to the wall.

Frontiers in surgery

Case Report View Source →
PubMed • 2016

Factors affecting Cook Gunther Tulip and Cook Celect inferior vena cava filter retrieval success.

Journal of vascular surgery. Venous and lymphatic disorders

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2014

Safety and efficacy of the Gunther Tulip retrievable vena cava filter: midterm outcomes.

Cardiovascular and interventional radiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2013

Successful removal of a Gunther tulip vena cava filter with wall-embedded hook and migration during a retrieval attempt.

Acta radiologica short reports

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2013

Retrieval of gunther tulip vena cava filter with thrombosed hook and a leg incorporated into the vena cava wall.

Annals of vascular diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2011

Endovascular repair of a perforation of the vena caval wall caused by the retrieval of a Gunther Tulip filter after long-term implantation.

Cardiovascular and interventional radiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2008

Form and function of vena cava filters: how do optional filters measure up?

Vascular

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2007

Evaluation of retrievability of the Gunther tulip vena cava filter.

Cardiovascular and interventional radiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2005

New optional IVC filter for percutaneous retrieval--in vitro evaluation of embolus capturing efficiency.

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin

RCT|prospective|retrospective|case Series|other View Source →
ClinicalTrials.gov

Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study

View Source →

Frequently Asked Questions

What are the clinical indications for Gunther Tulip Vena Cava Filter?

The filter is indicated for patients at risk of pulmonary embolism who cannot undergo anticoagulation therapy or have recurrent thromboembolic events.

What outcomes have been reported in clinical studies?

Studies report effective prevention of pulmonary embolism, but retrieval challenges and complications such as migration and embedding are noted.

What complications have been reported?

Safety data indicate complications such as filter migration, embedding in the vena cava wall, and vena cava perforation.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you